James George to Drug-Related Side Effects and Adverse Reactions
This is a "connection" page, showing publications James George has written about Drug-Related Side Effects and Adverse Reactions.
Connection Strength
2.799
-
Drug-induced thrombotic microangiopathy: An updated systematic review, 2014-2018. Am J Hematol. 2018 09; 93(9):E241-E243.
Score: 0.581
-
Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood. 2015 Jan 22; 125(4):616-8.
Score: 0.449
-
Drug-induced thrombocytopenia in children. Pediatr Blood Cancer. 2013 Dec; 60(12):1975-81.
Score: 0.412
-
Drug-induced thrombocytopenia: an updated systematic review, 2012. Drug Saf. 2012 Aug 01; 35(8):693-4.
Score: 0.383
-
Drug-induced thrombocytopenia: an updated systematic review, 2010. Drug Saf. 2011 May 01; 34(5):437-8.
Score: 0.351
-
Drug-induced thrombocytopenia: an updated systematic review, 2008. Drug Saf. 2009; 32(1):85-6.
Score: 0.299
-
Thrombotic microangiopathic syndromes associated with drugs, HIV infection, hematopoietic stem cell transplantation and cancer. Presse Med. 2012 Mar; 41(3 Pt 2):e177-88.
Score: 0.092
-
Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods. Blood. 2010 Sep 23; 116(12):2127-33.
Score: 0.082
-
The thrombotic thrombocytopenic purpura and hemolytic uremic syndromes: overview of pathogenesis (Experience of The Oklahoma TTP-HUS Registry, 1989-2007). Kidney Int Suppl. 2009 Feb; (112):S8-S10.
Score: 0.075
-
Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program. 2009; 153-8.
Score: 0.075